Sinus grafting using recombinant human tissue factor, platelet-rich plasma gel, autologous bone, and anorganic bovine bone mineral xenograft: Histologic analysis and case reports

International Journal of Oral and Maxillofacial Implants

Volumn 20, Issue 2, 2005, Pages 274-281

  Philippart, Pierre ^a   Daubie, Valéry ^b   Pochet, Roland ^b  

^a Bracops Hospital   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Angiogenesis; Bone regeneration; Immunohistochemistry; Inflammation markers; S100 proteins

Indexed keywords

RECOMBINANT THROMBOPLASTIN;

ARTICLE; BONE GRAFT; BONE MINERAL; BONE REGENERATION; CALVARIA; CASE REPORT; CELL CULTURE; COW; EDENTULOUSNESS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MAXILLARY SINUS; OSSIFICATION; OSTEOBLAST; OSTEOCYTE; PASTE; PERIODONTAL DISEASE; POWDER; THROMBOCYTE RICH PLASMA; XENOGRAFT;

ALVEOLAR RIDGE AUGMENTATION; ANIMALS; BONE REGENERATION; BONE SUBSTITUTES; BONE TRANSPLANTATION; CALGRANULIN A; CATTLE; FEMALE; FOLLOW-UP STUDIES; HEMOSTATICS; HUMANS; MALE; MAXILLA; MAXILLARY SINUS; MIDDLE AGED; OSTEOBLASTS; OSTEOCYTES; PLASMA; PLATELET TRANSFUSION; THROMBOPLASTIN; TRANSPLANTATION, HETEROLOGOUS;

EID: 17844380745     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Jensen OT, Shulman LB, Block MS, Iacono VJ. Report of the Sinus Consensus Conference of 1996. Int J Oral Maxillofac Implants 1998(suppl);13:11-45.
2. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 1989;3:192-195.
3. Cawood JI, Howell RA. A classification of edentulous jaws. Int J Oral Maxillofac Surg 1988;17:232-236.
4. Donovan MG, Dickerson NC, Hanson LJ, Gustafson RB. Maxillary and mandibular reconstruction using calvarial bone grafts and Brånemark implants. A preliminary report. J Oral Maxillofac Surg 1994;52:588-594.
5. Donovan MG, Dickerson NC, Hellstein JW, Hanson LJ. Autologous calvarial and iliac onlay bone grafts in miniature swine. J Oral Maxillofac Surg 1993;51:898-903.
6. Kaptein ML, Hoogstraten J, de Putter C, de Lange GL, Blijdorp PA. Dental implants in the atrophic maxilla: Measurements of patients' satisfaction and treatment experience. Clin Oral Implants Res 1998;9:321-326.
7. Kline RM Jr, Wolfe SA. Complications associated with the harvesting of cranial bone grafts. Plast Reconstr Surg 1995;95:5-13.
8. Keen M. Complications of harvesting cranial bone grafts [letter]. Plast Reconstr Surg 1995;96:1753.
9. Hallman M, Cederlund A, Lindskog S, Lundgren S, Sennerby L. A clinical histologic study of bovine hydroxyapatite in combination with autogenous bone and fibrin glue for maxillary sinus floor augmentation. Results after 6 to 8 months of healing. Clin Oral Implants Res 2001;12:135-143.
10. Wheeler SL, Holmes RE, Calhoun CJ. Six-year clinical and histologic study of sinus-lift grafts. Int J Oral Maxillofac Implants 1996;11:26-34.
11. Cordioli G, Mazzocco C, Schepers E, Brugnolo E, Majzoub Z. Maxillary sinus floor augmentation using bioactive glass granules and autogenous bone with simultaneous implant placement. Clinical and histological findings. Clin Oral Implants Res 2001;12:270-278.
12. Fugazzotto PA, Vlassis J. Long-term success of sinus augmentation using various surgical approaches and grafting materials. Int J Oral Maxillofac Implants 1998;13:52-58.
13. Van den Bergh JPA, ten Bruggenkate CM, Krekeler G, Tuinzing DB. Maxillary sinus floor elevation and grafting with human demineralized freeze dried bone. Clin Oral Implants Res 2000;11:487-493.
14. Watzek G, Weber R, Bernhart T, Ulm C, Haas R. Treatment of patients with extreme maxillary atrophy using sinus floor augmentation and implants: Preliminary results. Int J Oral Maxillofac Surg 1998;27:428-434.
15. Quinones CR, Hurzeler MB, Schüpbach P, et al. Maxillary sinus augmentation using different grafting materials and osseointegrated dental implants in monkeys. Part II. Evaluation of porous hydroxyapatite as a grafting material. Clin Oral Implants Res 1997;8:487-496.
16. Quinones CR, Hurzeler MB, Schüpbach P, Arnold DR, Strub JR, Caffesse RG. Maxillary sinus augmentation using different grafting materials and dental implants in monkeys. Part IV. Evaluation of hydroxyapatite-coated implants. Clin Oral Implants Res 1997;8:497-505.
17. Lynch SE, Genco RJ, Marx RE. Tissue Engineering: Applications in Maxillofacial Surgery and Periodontics. Chicago: Quintessence, 1999:34-38.
18. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff K. Platelet rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:638-646.
19. Slater M, Patava J, Kingham K, Mason RS. Involvement of platelets in stimulating osteogenic activity. J Orthop Res 1995;13:655-663.
20. Whitman DH, Berry RL, Green DM. Platelet gel: An autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 1997;55:1294-1299.
21. Gruber R, Varga F, Fischer MB, Watzek G. Platelets stimulate proliferation of bone cells: Involvement of platelet-derived growth factor, microparticles and membranes. Clin Oral Implants Res 2002;13:529-535.
22. Philippart P, Brasseur M, Hoyaux D, Pochet R. Human recombinant tissue factor, platelet-rich plasma, and tetracycline induce a high-quality human bone graft: A 5-year survey. Int J Oral Maxillofac Implants 2003;18:411-416.
23. Roth J, Vogl T, Sorg C, Sunderkotter C. Phagocyte-specific S100 proteins: A novel group of proinflammatory molecules. Trends Immunol 2003;24:155-158.
24. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta 1999;1450:191-231.
25. Schäfer BW, Heizmann CW. The S100 family of EF-hand calcium-binding proteins functions and pathology. Trends Biochem Sci 1996;21:134-140.
26. Kligman D, Hilt DC. The S100 protein family. Trends Biochem Sci 1988;13:437-443.
27. Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 1997;272:9496-9502.
28. Duarte WR, Shibata T, Takenaga K, et al. S100A4: A novel negative regulator of mineralization and osteoblast differentiation. J Bone Miner Res 2003;18:493-501.
29. Kuznicki J, Kordowska J, Puzianowska M, Wozniewicz BM. Calcyclin as a marker of human epithelial cells and fibroblasts. Exp Cell Res 1992;2:425-430.
30. Morrissey JH. Tissue factor: An enzyme cofactor and a true receptor. Thromb Haemost 2001;86:66-74.
31. Hoyaux D, Boom A, Van Den Bosch L, et al. S100A6 overexpression within astrocytes associated with impaired axons from both ALS mouse model and human patients. J Neuropathol Exp Neurol 2002;61:736-744.
32. El-Hakim IE. The effect of fibrin stabilizing factor (FXIII) on healing of bone defects in normal and uncontrolled diabetic rats. Int J Oral Maxillofac Surg 1999;28:304-308.
33. Dhall TZ, Shah GA, Ferguson IA, Dhall DP. Fibrin network structure: Modification by platelets. Thromb Haemost 1983;49:42-46.
34. Tawes RL, Sydorak GR, DuVall TB. Autologous fibrin glue: The last step in operative hemostasis. Am J Surg 1994;168:120-122.
35. Martinowitz U, Spotnitz WD. Fibrin tissue adhesives. Thromb Haemost 1997;78:661-666.
36. Albrektsson T, Bach A, Edshage S, Jonsson A. Fibrin adhesive system (FAS) influence on bone healing rate: A microradiographical evaluation using the bone growth chamber. Acta Orthop Scand 1982;53:757-766.
37. Muller I, Klocke A, Alex M, et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J 2003;17:476-478.
38. Komiyama Y, Pedersen AH, Kisiel W. Proteolytic activation of human factors IX and X by recombinant human factor VIIa: Effects of calcium, phospholipids, and tissue factor. Biochemistry 1990;29:9418-9425.
39. Ruf W, Dorfleutner A, Riewald M. Specificity of coagulation factor signaling. J Thromb Haemost 2003;1:1495-1503.
40. Martin DMA, Boys CWG, Ruf W. Tissue factor: Molecular recognition and cofactor function. FASEB J 1995;9:852-859.
41. Corseaux D, Meurice T, Six J, et al. Basic fibroblast growth factor increases tissue factor expression in circulating monocytes and in vascular wall. Circulation 2000;101:2000-2006.
42. Meisel SR, Shechter M, Xu XP, Edgington TS, Cercek B, Shah PK. Platelet-induced expression of tissue factor procoagulant activity in freshly isolated human mononuclear cells: Implications for experimental use. Clin Lab Haematol 2003;25:321-325.
43. Krishnaswamy S. The interaction of human factor VIIa with tissue factor. J Biol Chem 1992;267:23696-24706.
44. Lawson JH, Mann KG. Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation. J Biol Chem 1991;266:11317-11327.
45. Siegbahn A, Johnell M, Rorsman C, Ezban M, Heldin CH, Ronnstrand L. Binding of factor VIIa to tissue factor on human fibroblasts leads to activation of phospholipase C and enhanced PDGF-BB-stimulated chemotaxis. Blood 2000;96:3452-3458.
46. Cunningham MA, Romas P, Hutchinson P, Holdsworth SR, Tipping PG. Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood 1999;94:3413-3420.
47. Ollivier V, Bentolila S, Chabbat J, Hakim J, de Prost D. Tissue factor-dependent vascular endothelial growth factor production by human fibroblasts in response to activated factor VII. Blood 1998;91:2698-2703.
48. Chen J, Bierhaus A, Schiekofer S, et al. Tissue factor - A receptor involved in the control of cellular properties, including angiogenesis. Thromb Haemost 2001;86:334-345.
49. Versteeg HH, Peppelenbosch MP, Spek CA. Tissue factor signal transduction in angiogenesis. Carcinogenesis 2003;24:1009-1013.
50. Watanabe T, Yasuda M, Yamamoto T. Angiogenesis induced by tissue factor in vitro and in vivo. Thromb Res 1999;96:183-189.